Health care stocks declined Wednesday afternoon, with the NYSE Health Care Index falling 1% and the Health Care Select Sector SPDR Fund (XLV) dropping 1.2%.
The iShares Biotechnology ETF (IBB) eased 0.3%.
In corporate news, Patterson (PDCO) agreed to be acquired and taken private by health care investment firm Patient Square Capital in a deal worth $4.1 billion, including the refinancing of the dental and animal health equipment distributor's receivables facilities. Patterson shares surged 34%.
Bausch + Lomb (BLCO) shares tumbled nearly 14% after Citigroup downgraded the company's stock to neutral from buy, and the Financial Times reported that Blackstone (BX) has decided not to proceed with a joint takeover bid for Bausch + Lomb.
Q32 Bio (QTTB) shares plunged 73% after multiple downgrades and price target cuts following results from the company's mid-stage clinical trial of an experimental treatment for atopic dermatitis.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。